Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (v3.5.4) indicating a small internal update to the page version. No substantive content changes to the study details or layout are present.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.3' was added and the previous tag 'Revision: v3.5.2' was removed, indicating the page was updated to version 3.5.3. This reflects a minor update to the page metadata.
    Difference
    0.1%
    Check dated 2026-04-30T15:30:42.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added and v3.5.0 was removed. This appears to be a metadata update with no changes to the study data, eligibility criteria, or results presented.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:56.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing v3.4.3. No study details or user-facing content appear to be altered.
    Difference
    0.1%
    Check dated 2026-03-18T19:56:37.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:59:29.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Gastric cancer is added as a related MedlinePlus topic and the Genetic and Rare Diseases Information Center is referenced in the Resources section.
    Difference
    0.2%
    Check dated 2026-02-18T07:14:23.000Z thumbnail image

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.